source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[disease]	characteristics[biological replicate]	characteristics[enrichment process]	characteristics[enrichment method]	characteristics[treatment]	assay name	technology type	comment[plasmodium strain]	comment[proteomexchange accession number]	comment[proteomics data acquisition method]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[technical replicate]	comment[label]	comment[instrument]	comment[dissociation method]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[enrichment method]	factor value[treatment]	comment[sdrf version]	comment[sdrf template]
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 1	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1.raw	1	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 1	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1.raw	1	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 1	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1.raw	1	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 1	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1.raw	1	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 1	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1.raw	1	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 1	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1.raw	1	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 2	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1r.raw	1	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 2	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1r.raw	1	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 2	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1r.raw	1	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 2	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1r.raw	1	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 2	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1r.raw	1	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 2	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_1r.raw	1	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 3	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10.raw	10	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 3	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10.raw	10	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 3	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10.raw	10	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 3	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10.raw	10	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 3	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10.raw	10	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 3	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10.raw	10	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 4	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10r.raw	10	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 4	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10r.raw	10	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 4	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10r.raw	10	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 4	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10r.raw	10	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 4	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10r.raw	10	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 4	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_10r.raw	10	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 5	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11.raw	11	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 5	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11.raw	11	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 5	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11.raw	11	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 5	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11.raw	11	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 5	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11.raw	11	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 5	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11.raw	11	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 6	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11r.raw	11	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 6	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11r.raw	11	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 6	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11r.raw	11	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 6	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11r.raw	11	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 6	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11r.raw	11	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 6	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_11r.raw	11	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 7	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12.raw	12	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 7	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12.raw	12	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 7	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12.raw	12	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 7	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12.raw	12	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 7	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12.raw	12	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 7	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12.raw	12	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 8	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12r.raw	12	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 8	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12r.raw	12	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 8	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12r.raw	12	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 8	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12r.raw	12	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 8	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12r.raw	12	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 8	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_12r.raw	12	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 9	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13.raw	13	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 9	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13.raw	13	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 9	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13.raw	13	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 9	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13.raw	13	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 9	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13.raw	13	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 9	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13.raw	13	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 10	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13r.raw	13	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 10	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13r.raw	13	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 10	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13r.raw	13	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 10	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13r.raw	13	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 10	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13r.raw	13	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 10	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_13r.raw	13	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 11	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2.raw	2	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 11	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2.raw	2	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 11	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2.raw	2	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 11	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2.raw	2	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 11	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2.raw	2	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 11	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2.raw	2	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 12	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2r.raw	2	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 12	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2r.raw	2	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 12	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2r.raw	2	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 12	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2r.raw	2	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 12	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2r.raw	2	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 12	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_2r.raw	2	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 13	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3.raw	3	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 13	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3.raw	3	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 13	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3.raw	3	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 13	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3.raw	3	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 13	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3.raw	3	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 13	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3.raw	3	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 14	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3r.raw	3	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 14	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3r.raw	3	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 14	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3r.raw	3	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 14	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3r.raw	3	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 14	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3r.raw	3	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 14	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_3r.raw	3	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 15	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4.raw	4	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 15	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4.raw	4	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 15	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4.raw	4	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 15	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4.raw	4	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 15	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4.raw	4	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 15	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4.raw	4	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 16	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4r.raw	4	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 16	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4r.raw	4	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 16	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4r.raw	4	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 16	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4r.raw	4	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 16	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4r.raw	4	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 16	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_4r.raw	4	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 17	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5.raw	5	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 17	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5.raw	5	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 17	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5.raw	5	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 17	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5.raw	5	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 17	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5.raw	5	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 17	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5.raw	5	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 18	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5r.raw	5	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 18	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5r.raw	5	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 18	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5r.raw	5	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 18	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5r.raw	5	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 18	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5r.raw	5	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 18	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_5r.raw	5	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 19	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6.raw	6	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 19	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6.raw	6	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 19	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6.raw	6	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 19	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6.raw	6	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 19	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6.raw	6	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 19	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6.raw	6	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 20	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6r.raw	6	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 20	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6r.raw	6	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 20	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6r.raw	6	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 20	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6r.raw	6	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 20	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6r.raw	6	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 20	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_6r.raw	6	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 21	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7.raw	7	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 21	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7.raw	7	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 21	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7.raw	7	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 21	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7.raw	7	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 21	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7.raw	7	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 21	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7.raw	7	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 22	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7r.raw	7	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 22	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7r.raw	7	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 22	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7r.raw	7	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 22	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7r.raw	7	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 22	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7r.raw	7	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 22	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_7r.raw	7	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 23	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8.raw	8	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 23	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8.raw	8	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 23	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8.raw	8	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 23	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8.raw	8	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 23	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8.raw	8	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 23	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8.raw	8	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 24	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8r.raw	8	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 24	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8r.raw	8	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 24	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8r.raw	8	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 24	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8r.raw	8	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 24	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8r.raw	8	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 24	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_8r.raw	8	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 25	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9.raw	9	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 25	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9.raw	9	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 25	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9.raw	9	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 25	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9.raw	9	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 25	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9.raw	9	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 25	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9.raw	9	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 1	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 26	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9r.raw	9	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 2	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 26	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9r.raw	9	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 3	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 26	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9r.raw	9	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 4	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 26	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9r.raw	9	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 5	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 26	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9r.raw	9	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 6	plasmodium falciparum	not applicable	not applicable	not applicable	1	no enrichment	not applicable	not applicable	run 26	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_FT_exp1_9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_FT_exp1_9r.raw	9	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 27	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1.raw	1	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 27	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1.raw	1	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 27	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1.raw	1	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 27	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1.raw	1	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 27	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1.raw	1	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 27	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1.raw	1	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 28	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1r.raw	1	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 28	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1r.raw	1	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 28	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1r.raw	1	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 28	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1r.raw	1	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 28	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1r.raw	1	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 28	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E1r.raw	1	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 29	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10.raw	10	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 29	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10.raw	10	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 29	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10.raw	10	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 29	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10.raw	10	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 29	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10.raw	10	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 29	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10.raw	10	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 30	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10r.raw	10	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 30	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10r.raw	10	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 30	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10r.raw	10	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 30	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10r.raw	10	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 30	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10r.raw	10	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 30	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E10r.raw	10	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 31	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11.raw	11	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 31	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11.raw	11	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 31	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11.raw	11	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 31	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11.raw	11	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 31	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11.raw	11	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 31	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11.raw	11	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 32	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11r.raw	11	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 32	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11r.raw	11	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 32	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11r.raw	11	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 32	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11r.raw	11	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 32	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11r.raw	11	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 32	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E11r.raw	11	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 33	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12.raw	12	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 33	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12.raw	12	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 33	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12.raw	12	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 33	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12.raw	12	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 33	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12.raw	12	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 33	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12.raw	12	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 34	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12r.raw	12	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 34	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12r.raw	12	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 34	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12r.raw	12	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 34	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12r.raw	12	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 34	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12r.raw	12	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 34	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E12r.raw	12	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 35	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13.raw	13	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 35	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13.raw	13	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 35	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13.raw	13	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 35	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13.raw	13	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 35	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13.raw	13	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 35	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13.raw	13	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 36	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13r.raw	13	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 36	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13r.raw	13	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 36	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13r.raw	13	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 36	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13r.raw	13	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 36	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13r.raw	13	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 36	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E13r.raw	13	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 37	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14.raw	14	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 37	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14.raw	14	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 37	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14.raw	14	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 37	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14.raw	14	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 37	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14.raw	14	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 37	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14.raw	14	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 38	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14r.raw	14	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 38	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14r.raw	14	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 38	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14r.raw	14	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 38	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14r.raw	14	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 38	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14r.raw	14	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 38	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E14r.raw	14	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 39	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15.raw	15	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 39	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15.raw	15	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 39	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15.raw	15	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 39	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15.raw	15	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 39	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15.raw	15	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 39	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15.raw	15	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 40	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15r.raw	15	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 40	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15r.raw	15	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 40	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15r.raw	15	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 40	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15r.raw	15	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 40	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15r.raw	15	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 40	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E15r.raw	15	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 41	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16.raw	16	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 41	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16.raw	16	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 41	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16.raw	16	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 41	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16.raw	16	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 41	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16.raw	16	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 41	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16.raw	16	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 42	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16r.raw	16	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 42	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16r.raw	16	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 42	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16r.raw	16	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 42	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16r.raw	16	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 42	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16r.raw	16	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 42	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E16r.raw	16	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 43	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2.raw	2	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 43	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2.raw	2	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 43	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2.raw	2	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 43	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2.raw	2	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 43	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2.raw	2	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 43	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2.raw	2	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 44	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2r.raw	2	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 44	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2r.raw	2	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 44	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2r.raw	2	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 44	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2r.raw	2	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 44	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2r.raw	2	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 44	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E2r.raw	2	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 45	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3.raw	3	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 45	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3.raw	3	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 45	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3.raw	3	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 45	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3.raw	3	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 45	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3.raw	3	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 45	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3.raw	3	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 46	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3r.raw	3	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 46	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3r.raw	3	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 46	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3r.raw	3	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 46	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3r.raw	3	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 46	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3r.raw	3	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 46	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E3r.raw	3	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 47	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4.raw	4	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 47	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4.raw	4	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 47	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4.raw	4	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 47	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4.raw	4	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 47	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4.raw	4	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 47	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4.raw	4	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 48	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4r.raw	4	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 48	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4r.raw	4	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 48	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4r.raw	4	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 48	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4r.raw	4	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 48	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4r.raw	4	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 48	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E4r.raw	4	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 49	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5.raw	5	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 49	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5.raw	5	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 49	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5.raw	5	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 49	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5.raw	5	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 49	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5.raw	5	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 49	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5.raw	5	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 50	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5r.raw	5	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 50	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5r.raw	5	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 50	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5r.raw	5	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 50	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5r.raw	5	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 50	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5r.raw	5	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 50	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E5r.raw	5	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 51	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6.raw	6	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 51	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6.raw	6	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 51	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6.raw	6	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 51	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6.raw	6	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 51	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6.raw	6	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 51	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6.raw	6	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 52	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6r.raw	6	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 52	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6r.raw	6	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 52	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6r.raw	6	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 52	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6r.raw	6	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 52	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6r.raw	6	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 52	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E6r.raw	6	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 53	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7.raw	7	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 53	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7.raw	7	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 53	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7.raw	7	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 53	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7.raw	7	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 53	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7.raw	7	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 53	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7.raw	7	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 54	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7r.raw	7	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 54	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7r.raw	7	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 54	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7r.raw	7	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 54	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7r.raw	7	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 54	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7r.raw	7	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 54	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E7r.raw	7	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 55	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8.raw	8	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 55	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8.raw	8	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 55	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8.raw	8	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 55	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8.raw	8	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 55	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8.raw	8	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 55	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8.raw	8	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 56	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8r.raw	8	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 56	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8r.raw	8	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 56	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8r.raw	8	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 56	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8r.raw	8	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 56	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8r.raw	8	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 56	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E8r.raw	8	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 57	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9.raw	9	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 57	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9.raw	9	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 57	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9.raw	9	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 57	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9.raw	9	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 57	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9.raw	9	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 57	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9.raw	9	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 7	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 58	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9r.raw	9	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 8	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 58	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9r.raw	9	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 9	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 58	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9r.raw	9	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 10	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 58	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9r.raw	9	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 11	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 58	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9r.raw	9	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 12	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 58	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_IMAC_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_IMAC_exp1_E9r.raw	9	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 59	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1.raw	1	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 59	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1.raw	1	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 59	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1.raw	1	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 59	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1.raw	1	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 59	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1.raw	1	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 59	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1.raw	1	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 60	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1r.raw	1	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 60	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1r.raw	1	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 60	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1r.raw	1	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 60	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1r.raw	1	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 60	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1r.raw	1	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 60	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E1r.raw	1	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 61	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10.raw	10	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 61	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10.raw	10	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 61	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10.raw	10	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 61	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10.raw	10	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 61	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10.raw	10	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 61	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10.raw	10	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 62	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10r.raw	10	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 62	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10r.raw	10	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 62	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10r.raw	10	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 62	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10r.raw	10	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 62	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10r.raw	10	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 62	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E10r.raw	10	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 63	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11.raw	11	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 63	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11.raw	11	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 63	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11.raw	11	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 63	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11.raw	11	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 63	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11.raw	11	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 63	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11.raw	11	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 64	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11r.raw	11	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 64	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11r.raw	11	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 64	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11r.raw	11	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 64	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11r.raw	11	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 64	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11r.raw	11	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 64	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E11r.raw	11	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 65	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12.raw	12	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 65	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12.raw	12	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 65	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12.raw	12	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 65	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12.raw	12	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 65	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12.raw	12	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 65	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12.raw	12	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 66	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12r.raw	12	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 66	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12r.raw	12	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 66	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12r.raw	12	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 66	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12r.raw	12	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 66	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12r.raw	12	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 66	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E12r.raw	12	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 67	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13.raw	13	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 67	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13.raw	13	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 67	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13.raw	13	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 67	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13.raw	13	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 67	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13.raw	13	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 67	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13.raw	13	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 68	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13r.raw	13	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 68	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13r.raw	13	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 68	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13r.raw	13	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 68	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13r.raw	13	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 68	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13r.raw	13	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 68	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E13r.raw	13	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 69	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14.raw	14	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 69	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14.raw	14	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 69	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14.raw	14	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 69	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14.raw	14	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 69	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14.raw	14	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 69	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14.raw	14	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 70	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14r.raw	14	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 70	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14r.raw	14	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 70	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14r.raw	14	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 70	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14r.raw	14	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 70	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14r.raw	14	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 70	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E14r.raw	14	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 71	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2.raw	2	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 71	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2.raw	2	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 71	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2.raw	2	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 71	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2.raw	2	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 71	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2.raw	2	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 71	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2.raw	2	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 72	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2r.raw	2	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 72	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2r.raw	2	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 72	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2r.raw	2	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 72	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2r.raw	2	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 72	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2r.raw	2	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 72	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E2r.raw	2	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 73	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3.raw	3	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 73	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3.raw	3	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 73	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3.raw	3	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 73	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3.raw	3	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 73	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3.raw	3	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 73	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3.raw	3	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 74	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3r.raw	3	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 74	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3r.raw	3	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 74	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3r.raw	3	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 74	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3r.raw	3	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 74	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3r.raw	3	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 74	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E3r.raw	3	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 75	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4.raw	4	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 75	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4.raw	4	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 75	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4.raw	4	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 75	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4.raw	4	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 75	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4.raw	4	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 75	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4.raw	4	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 76	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4r.raw	4	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 76	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4r.raw	4	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 76	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4r.raw	4	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 76	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4r.raw	4	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 76	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4r.raw	4	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 76	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E4r.raw	4	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 77	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5.raw	5	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 77	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5.raw	5	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 77	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5.raw	5	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 77	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5.raw	5	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 77	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5.raw	5	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 77	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5.raw	5	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 78	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5r.raw	5	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 78	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5r.raw	5	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 78	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5r.raw	5	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 78	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5r.raw	5	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 78	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5r.raw	5	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 78	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E5r.raw	5	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 79	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6.raw	6	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 79	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6.raw	6	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 79	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6.raw	6	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 79	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6.raw	6	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 79	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6.raw	6	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 79	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6.raw	6	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 80	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6r.raw	6	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 80	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6r.raw	6	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 80	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6r.raw	6	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 80	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6r.raw	6	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 80	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6r.raw	6	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 80	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E6r.raw	6	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 81	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7.raw	7	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 81	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7.raw	7	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 81	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7.raw	7	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 81	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7.raw	7	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 81	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7.raw	7	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 81	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7.raw	7	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 82	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7r.raw	7	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 82	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7r.raw	7	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 82	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7r.raw	7	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 82	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7r.raw	7	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 82	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7r.raw	7	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 82	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E7r.raw	7	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 83	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8.raw	8	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 83	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8.raw	8	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 83	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8.raw	8	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 83	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8.raw	8	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 83	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8.raw	8	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 83	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8.raw	8	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 84	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8r.raw	8	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 84	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8r.raw	8	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 84	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8r.raw	8	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 84	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8r.raw	8	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 84	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8r.raw	8	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 84	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E8r.raw	8	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 85	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9.raw	9	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 85	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9.raw	9	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 85	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9.raw	9	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 85	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9.raw	9	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 85	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9.raw	9	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 85	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9.raw	9	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 13	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 86	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9r.raw	9	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 14	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 86	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9r.raw	9	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 15	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 86	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9r.raw	9	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 16	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 86	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9r.raw	9	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 17	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 86	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9r.raw	9	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 18	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 86	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp1_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp1_E9r.raw	9	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 87	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1.raw	1	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 87	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1.raw	1	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 87	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1.raw	1	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 87	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1.raw	1	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 87	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1.raw	1	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 87	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1.raw	1	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 88	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1r.raw	1	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 88	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1r.raw	1	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 88	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1r.raw	1	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 88	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1r.raw	1	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 88	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1r.raw	1	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 88	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E1r.raw	1	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 89	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10.raw	10	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 89	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10.raw	10	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 89	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10.raw	10	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 89	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10.raw	10	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 89	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10.raw	10	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 89	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10.raw	10	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 90	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10r.raw	10	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 90	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10r.raw	10	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 90	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10r.raw	10	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 90	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10r.raw	10	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 90	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10r.raw	10	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 90	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E10r.raw	10	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 91	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11.raw	11	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 91	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11.raw	11	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 91	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11.raw	11	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 91	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11.raw	11	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 91	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11.raw	11	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 91	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11.raw	11	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 92	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11r.raw	11	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 92	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11r.raw	11	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 92	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11r.raw	11	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 92	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11r.raw	11	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 92	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11r.raw	11	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 92	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E11r.raw	11	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 93	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12.raw	12	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 93	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12.raw	12	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 93	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12.raw	12	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 93	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12.raw	12	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 93	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12.raw	12	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 93	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12.raw	12	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 94	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12r.raw	12	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 94	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12r.raw	12	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 94	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12r.raw	12	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 94	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12r.raw	12	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 94	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12r.raw	12	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 94	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E12r.raw	12	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 95	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13.raw	13	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 95	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13.raw	13	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 95	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13.raw	13	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 95	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13.raw	13	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 95	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13.raw	13	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 95	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13.raw	13	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 96	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13r.raw	13	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 96	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13r.raw	13	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 96	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13r.raw	13	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 96	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13r.raw	13	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 96	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13r.raw	13	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 96	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E13r.raw	13	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 97	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14.raw	14	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 97	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14.raw	14	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 97	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14.raw	14	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 97	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14.raw	14	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 97	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14.raw	14	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 97	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14.raw	14	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 98	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14r.raw	14	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 98	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14r.raw	14	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 98	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14r.raw	14	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 98	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14r.raw	14	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 98	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14r.raw	14	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 98	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E14r.raw	14	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 99	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15.raw	15	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 99	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15.raw	15	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 99	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15.raw	15	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 99	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15.raw	15	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 99	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15.raw	15	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 99	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15.raw	15	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 100	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15r.raw	15	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 100	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15r.raw	15	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 100	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15r.raw	15	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 100	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15r.raw	15	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 100	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15r.raw	15	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 100	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E15r.raw	15	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 101	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16.raw	16	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 101	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16.raw	16	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 101	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16.raw	16	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 101	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16.raw	16	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 101	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16.raw	16	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 101	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16.raw	16	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 102	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16r.raw	16	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 102	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16r.raw	16	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 102	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16r.raw	16	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 102	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16r.raw	16	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 102	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16r.raw	16	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 102	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E16r.raw	16	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 103	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17.raw	17	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 103	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17.raw	17	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 103	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17.raw	17	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 103	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17.raw	17	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 103	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17.raw	17	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 103	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17.raw	17	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 104	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17r.raw	17	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 104	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17r.raw	17	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 104	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17r.raw	17	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 104	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17r.raw	17	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 104	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17r.raw	17	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 104	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E17r.raw	17	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 105	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18.raw	18	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 105	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18.raw	18	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 105	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18.raw	18	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 105	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18.raw	18	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 105	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18.raw	18	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 105	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18.raw	18	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 106	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18r.raw	18	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 106	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18r.raw	18	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 106	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18r.raw	18	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 106	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18r.raw	18	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 106	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18r.raw	18	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 106	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E18r.raw	18	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 107	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19.raw	19	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 107	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19.raw	19	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 107	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19.raw	19	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 107	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19.raw	19	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 107	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19.raw	19	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 107	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19.raw	19	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 108	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19r.raw	19	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 108	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19r.raw	19	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 108	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19r.raw	19	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 108	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19r.raw	19	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 108	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19r.raw	19	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 108	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E19r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E19r.raw	19	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 109	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2.raw	2	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 109	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2.raw	2	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 109	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2.raw	2	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 109	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2.raw	2	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 109	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2.raw	2	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 109	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2.raw	2	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 110	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2r.raw	2	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 110	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2r.raw	2	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 110	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2r.raw	2	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 110	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2r.raw	2	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 110	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2r.raw	2	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 110	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E2r.raw	2	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 111	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20.raw	20	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 111	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20.raw	20	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 111	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20.raw	20	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 111	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20.raw	20	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 111	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20.raw	20	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 111	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20.raw	20	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 112	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20r.raw	20	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 112	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20r.raw	20	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 112	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20r.raw	20	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 112	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20r.raw	20	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 112	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20r.raw	20	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 112	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E20r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E20r.raw	20	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 113	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21.raw	21	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 113	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21.raw	21	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 113	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21.raw	21	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 113	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21.raw	21	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 113	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21.raw	21	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 113	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21.raw	21	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 114	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21r.raw	21	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 114	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21r.raw	21	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 114	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21r.raw	21	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 114	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21r.raw	21	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 114	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21r.raw	21	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 114	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E21r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E21r.raw	21	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 115	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22.raw	22	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 115	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22.raw	22	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 115	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22.raw	22	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 115	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22.raw	22	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 115	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22.raw	22	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 115	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22.raw	22	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 116	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22r.raw	22	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 116	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22r.raw	22	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 116	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22r.raw	22	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 116	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22r.raw	22	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 116	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22r.raw	22	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 116	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E22r.raw	22	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 117	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23.raw	23	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 117	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23.raw	23	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 117	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23.raw	23	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 117	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23.raw	23	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 117	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23.raw	23	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 117	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23.raw	23	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 118	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23r.raw	23	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 118	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23r.raw	23	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 118	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23r.raw	23	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 118	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23r.raw	23	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 118	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23r.raw	23	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 118	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E23r.raw	23	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 119	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24.raw	24	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 119	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24.raw	24	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 119	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24.raw	24	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 119	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24.raw	24	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 119	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24.raw	24	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 119	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24.raw	24	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 120	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24r.raw	24	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 120	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24r.raw	24	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 120	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24r.raw	24	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 120	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24r.raw	24	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 120	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24r.raw	24	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 120	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E24r.raw	24	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 121	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3.raw	3	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 121	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3.raw	3	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 121	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3.raw	3	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 121	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3.raw	3	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 121	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3.raw	3	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 121	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3.raw	3	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 122	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3r.raw	3	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 122	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3r.raw	3	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 122	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3r.raw	3	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 122	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3r.raw	3	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 122	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3r.raw	3	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 122	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E3r.raw	3	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 123	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4.raw	4	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 123	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4.raw	4	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 123	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4.raw	4	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 123	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4.raw	4	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 123	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4.raw	4	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 123	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4.raw	4	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 124	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4r.raw	4	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 124	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4r.raw	4	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 124	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4r.raw	4	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 124	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4r.raw	4	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 124	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4r.raw	4	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 124	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E4r.raw	4	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 125	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5.raw	5	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 125	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5.raw	5	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 125	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5.raw	5	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 125	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5.raw	5	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 125	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5.raw	5	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 125	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5.raw	5	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 126	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5r.raw	5	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 126	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5r.raw	5	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 126	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5r.raw	5	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 126	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5r.raw	5	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 126	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5r.raw	5	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 126	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E5r.raw	5	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 127	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6.raw	6	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 127	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6.raw	6	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 127	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6.raw	6	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 127	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6.raw	6	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 127	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6.raw	6	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 127	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6.raw	6	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 128	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6r.raw	6	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 128	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6r.raw	6	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 128	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6r.raw	6	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 128	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6r.raw	6	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 128	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6r.raw	6	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 128	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E6r.raw	6	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 129	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7.raw	7	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 129	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7.raw	7	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 129	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7.raw	7	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 129	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7.raw	7	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 129	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7.raw	7	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 129	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7.raw	7	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 130	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7r.raw	7	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 130	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7r.raw	7	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 130	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7r.raw	7	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 130	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7r.raw	7	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 130	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7r.raw	7	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 130	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E7r.raw	7	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 131	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8.raw	8	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 131	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8.raw	8	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 131	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8.raw	8	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 131	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8.raw	8	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 131	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8.raw	8	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 131	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8.raw	8	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 132	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8r.raw	8	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 132	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8r.raw	8	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 132	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8r.raw	8	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 132	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8r.raw	8	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 132	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8r.raw	8	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 132	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E8r.raw	8	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 133	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9.raw	9	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 133	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9.raw	9	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 133	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9.raw	9	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 133	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9.raw	9	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 133	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9.raw	9	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 133	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9.raw	9	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 19	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 134	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9r.raw	9	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 20	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 134	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9r.raw	9	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 21	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	IC	run 134	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9r.raw	9	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 22	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC	run 134	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9r.raw	9	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 23	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	IMAC	EC-BA	run 134	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9r.raw	9	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 24	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 134	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3Plex_IMAC_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3Plex_IMAC_exp2_E9r.raw	9	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	IMAC	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 135	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1.raw	1	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 135	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1.raw	1	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 135	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1.raw	1	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 135	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1.raw	1	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 135	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1.raw	1	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 135	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1.raw	1	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 136	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1r.raw	1	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 136	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1r.raw	1	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 136	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1r.raw	1	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 136	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1r.raw	1	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 136	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1r.raw	1	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 136	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E1r.raw	1	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 137	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10.raw	10	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 137	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10.raw	10	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 137	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10.raw	10	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 137	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10.raw	10	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 137	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10.raw	10	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 137	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10.raw	10	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 138	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10r.raw	10	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 138	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10r.raw	10	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 138	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10r.raw	10	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 138	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10r.raw	10	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 138	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10r.raw	10	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 138	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E10r.raw	10	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 139	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11.raw	11	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 139	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11.raw	11	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 139	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11.raw	11	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 139	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11.raw	11	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 139	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11.raw	11	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 139	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11.raw	11	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 140	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11r.raw	11	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 140	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11r.raw	11	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 140	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11r.raw	11	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 140	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11r.raw	11	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 140	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11r.raw	11	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 140	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E11r.raw	11	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 141	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12.raw	12	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 141	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12.raw	12	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 141	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12.raw	12	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 141	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12.raw	12	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 141	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12.raw	12	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 141	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12.raw	12	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 142	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12r.raw	12	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 142	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12r.raw	12	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 142	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12r.raw	12	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 142	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12r.raw	12	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 142	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12r.raw	12	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 142	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E12r.raw	12	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 143	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13.raw	13	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 143	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13.raw	13	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 143	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13.raw	13	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 143	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13.raw	13	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 143	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13.raw	13	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 143	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13.raw	13	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 144	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13r.raw	13	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 144	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13r.raw	13	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 144	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13r.raw	13	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 144	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13r.raw	13	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 144	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13r.raw	13	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 144	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E13r.raw	13	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 145	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14.raw	14	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 145	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14.raw	14	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 145	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14.raw	14	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 145	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14.raw	14	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 145	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14.raw	14	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 145	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14.raw	14	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 146	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14r.raw	14	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 146	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14r.raw	14	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 146	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14r.raw	14	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 146	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14r.raw	14	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 146	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14r.raw	14	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 146	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E14r.raw	14	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 147	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15.raw	15	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 147	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15.raw	15	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 147	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15.raw	15	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 147	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15.raw	15	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 147	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15.raw	15	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 147	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15.raw	15	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 148	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15r.raw	15	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 148	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15r.raw	15	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 148	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15r.raw	15	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 148	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15r.raw	15	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 148	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15r.raw	15	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 148	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E15r.raw	15	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 149	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16.raw	16	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 149	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16.raw	16	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 149	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16.raw	16	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 149	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16.raw	16	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 149	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16.raw	16	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 149	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16.raw	16	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 150	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16r.raw	16	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 150	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16r.raw	16	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 150	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16r.raw	16	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 150	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16r.raw	16	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 150	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16r.raw	16	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 150	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E16r.raw	16	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 151	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17.raw	17	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 151	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17.raw	17	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 151	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17.raw	17	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 151	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17.raw	17	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 151	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17.raw	17	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 151	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17.raw	17	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 152	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17r.raw	17	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 152	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17r.raw	17	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 152	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17r.raw	17	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 152	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17r.raw	17	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 152	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17r.raw	17	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 152	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E17r.raw	17	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 153	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18.raw	18	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 153	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18.raw	18	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 153	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18.raw	18	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 153	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18.raw	18	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 153	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18.raw	18	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 153	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18.raw	18	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 154	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18r.raw	18	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 154	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18r.raw	18	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 154	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18r.raw	18	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 154	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18r.raw	18	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 154	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18r.raw	18	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 154	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E18r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E18r.raw	18	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 155	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2.raw	2	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 155	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2.raw	2	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 155	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2.raw	2	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 155	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2.raw	2	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 155	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2.raw	2	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 155	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2.raw	2	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 156	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2r.raw	2	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 156	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2r.raw	2	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 156	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2r.raw	2	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 156	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2r.raw	2	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 156	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2r.raw	2	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 156	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E2r.raw	2	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 157	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22.raw	22	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 157	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22.raw	22	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 157	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22.raw	22	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 157	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22.raw	22	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 157	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22.raw	22	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 157	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22.raw	22	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 158	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22r.raw	22	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 158	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22r.raw	22	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 158	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22r.raw	22	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 158	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22r.raw	22	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 158	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22r.raw	22	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 158	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E22r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E22r.raw	22	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 159	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23.raw	23	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 159	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23.raw	23	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 159	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23.raw	23	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 159	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23.raw	23	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 159	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23.raw	23	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 159	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23.raw	23	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 160	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23r.raw	23	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 160	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23r.raw	23	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 160	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23r.raw	23	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 160	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23r.raw	23	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 160	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23r.raw	23	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 160	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E23r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E23r.raw	23	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 161	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24.raw	24	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 161	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24.raw	24	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 161	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24.raw	24	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 161	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24.raw	24	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 161	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24.raw	24	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 161	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24.raw	24	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 162	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24r.raw	24	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 162	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24r.raw	24	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 162	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24r.raw	24	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 162	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24r.raw	24	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 162	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24r.raw	24	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 162	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E24r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E24r.raw	24	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 163	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25.raw	25	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 163	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25.raw	25	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 163	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25.raw	25	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 163	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25.raw	25	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 163	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25.raw	25	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 163	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25.raw	25	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 164	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25r.raw	25	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 164	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25r.raw	25	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 164	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25r.raw	25	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 164	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25r.raw	25	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 164	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25r.raw	25	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 164	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E25r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E25r.raw	25	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 165	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26.raw	26	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 165	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26.raw	26	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 165	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26.raw	26	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 165	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26.raw	26	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 165	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26.raw	26	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 165	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26.raw	26	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 166	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26r.raw	26	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 166	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26r.raw	26	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 166	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26r.raw	26	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 166	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26r.raw	26	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 166	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26r.raw	26	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 166	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E26r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E26r.raw	26	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 167	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27.raw	27	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 167	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27.raw	27	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 167	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27.raw	27	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 167	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27.raw	27	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 167	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27.raw	27	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 167	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27.raw	27	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 168	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27r.raw	27	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 168	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27r.raw	27	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 168	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27r.raw	27	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 168	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27r.raw	27	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 168	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27r.raw	27	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 168	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E27r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E27r.raw	27	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 169	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28.raw	28	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 169	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28.raw	28	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 169	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28.raw	28	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 169	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28.raw	28	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 169	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28.raw	28	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 169	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28.raw	28	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 170	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28r.raw	28	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 170	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28r.raw	28	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 170	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28r.raw	28	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 170	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28r.raw	28	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 170	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28r.raw	28	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 170	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E28r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E28r.raw	28	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 171	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29.raw	29	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 171	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29.raw	29	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 171	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29.raw	29	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 171	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29.raw	29	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 171	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29.raw	29	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 171	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29.raw	29	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 172	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29r.raw	29	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 172	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29r.raw	29	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 172	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29r.raw	29	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 172	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29r.raw	29	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 172	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29r.raw	29	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 172	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E29r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E29r.raw	29	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 173	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3.raw	3	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 173	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3.raw	3	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 173	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3.raw	3	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 173	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3.raw	3	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 173	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3.raw	3	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 173	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3.raw	3	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 174	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3r.raw	3	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 174	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3r.raw	3	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 174	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3r.raw	3	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 174	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3r.raw	3	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 174	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3r.raw	3	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 174	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E3r.raw	3	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 175	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30.raw	30	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 175	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30.raw	30	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 175	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30.raw	30	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 175	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30.raw	30	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 175	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30.raw	30	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 175	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30.raw	30	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 176	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30r.raw	30	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 176	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30r.raw	30	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 176	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30r.raw	30	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 176	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30r.raw	30	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 176	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30r.raw	30	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 176	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E30r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E30r.raw	30	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 177	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31.raw	31	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 177	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31.raw	31	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 177	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31.raw	31	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 177	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31.raw	31	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 177	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31.raw	31	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 177	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31.raw	31	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 178	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31r.raw	31	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 178	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31r.raw	31	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 178	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31r.raw	31	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 178	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31r.raw	31	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 178	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31r.raw	31	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 178	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E31r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E31r.raw	31	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 179	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32.raw	32	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 179	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32.raw	32	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 179	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32.raw	32	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 179	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32.raw	32	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 179	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32.raw	32	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 179	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32.raw	32	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 180	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32r.raw	32	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 180	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32r.raw	32	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 180	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32r.raw	32	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 180	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32r.raw	32	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 180	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32r.raw	32	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 180	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E32r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E32r.raw	32	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 181	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33.raw	33	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 181	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33.raw	33	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 181	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33.raw	33	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 181	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33.raw	33	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 181	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33.raw	33	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 181	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33.raw	33	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 182	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33r.raw	33	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 182	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33r.raw	33	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 182	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33r.raw	33	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 182	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33r.raw	33	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 182	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33r.raw	33	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 182	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E33r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E33r.raw	33	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 183	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34.raw	34	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 183	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34.raw	34	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 183	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34.raw	34	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 183	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34.raw	34	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 183	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34.raw	34	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 183	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34.raw	34	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 184	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34r.raw	34	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 184	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34r.raw	34	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 184	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34r.raw	34	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 184	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34r.raw	34	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 184	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34r.raw	34	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 184	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E34r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E34r.raw	34	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 185	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4.raw	4	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 185	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4.raw	4	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 185	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4.raw	4	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 185	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4.raw	4	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 185	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4.raw	4	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 185	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4.raw	4	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 186	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4r.raw	4	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 186	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4r.raw	4	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 186	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4r.raw	4	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 186	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4r.raw	4	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 186	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4r.raw	4	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 186	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E4r.raw	4	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 187	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5.raw	5	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 187	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5.raw	5	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 187	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5.raw	5	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 187	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5.raw	5	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 187	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5.raw	5	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 187	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5.raw	5	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 188	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5r.raw	5	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 188	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5r.raw	5	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 188	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5r.raw	5	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 188	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5r.raw	5	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 188	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5r.raw	5	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 188	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E5r.raw	5	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 189	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6.raw	6	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 189	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6.raw	6	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 189	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6.raw	6	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 189	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6.raw	6	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 189	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6.raw	6	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 189	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6.raw	6	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 190	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6r.raw	6	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 190	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6r.raw	6	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 190	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6r.raw	6	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 190	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6r.raw	6	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 190	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6r.raw	6	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 190	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E6r.raw	6	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 191	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7.raw	7	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 191	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7.raw	7	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 191	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7.raw	7	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 191	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7.raw	7	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 191	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7.raw	7	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 191	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7.raw	7	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 192	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7r.raw	7	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 192	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7r.raw	7	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 192	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7r.raw	7	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 192	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7r.raw	7	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 192	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7r.raw	7	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 192	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E7r.raw	7	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 193	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8.raw	8	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 193	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8.raw	8	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 193	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8.raw	8	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 193	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8.raw	8	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 193	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8.raw	8	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 193	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8.raw	8	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 194	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8r.raw	8	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 194	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8r.raw	8	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 194	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8r.raw	8	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 194	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8r.raw	8	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 194	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8r.raw	8	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 194	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E8r.raw	8	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 195	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9.raw	9	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 195	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9.raw	9	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 195	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9.raw	9	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 195	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9.raw	9	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 195	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9.raw	9	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 195	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9.raw	9	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 25	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 196	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9r.raw	9	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 26	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 196	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9r.raw	9	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 27	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	IC	run 196	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9r.raw	9	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 28	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC	run 196	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9r.raw	9	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 29	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	enrichment of phosphorylated protein	TiO2	EC-BA	run 196	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9r.raw	9	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 30	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 196	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_TiO2_exp2_E9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_TiO2_exp2_E9r.raw	9	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	TiO2	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 197	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1.raw	1	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 197	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1.raw	1	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 197	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1.raw	1	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 197	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1.raw	1	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 197	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1.raw	1	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 197	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1.raw	1	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 198	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1r.raw	1	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 198	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1r.raw	1	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 198	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1r.raw	1	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 198	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1r.raw	1	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 198	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1r.raw	1	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 198	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT1r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT1r.raw	1	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 199	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10.raw	10	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 199	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10.raw	10	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 199	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10.raw	10	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 199	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10.raw	10	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 199	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10.raw	10	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 199	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10.raw	10	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 200	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10r.raw	10	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 200	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10r.raw	10	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 200	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10r.raw	10	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 200	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10r.raw	10	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 200	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10r.raw	10	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 200	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT10r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT10r.raw	10	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 201	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11.raw	11	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 201	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11.raw	11	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 201	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11.raw	11	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 201	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11.raw	11	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 201	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11.raw	11	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 201	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11.raw	11	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 202	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11r.raw	11	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 202	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11r.raw	11	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 202	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11r.raw	11	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 202	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11r.raw	11	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 202	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11r.raw	11	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 202	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT11r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT11r.raw	11	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 203	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12.raw	12	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 203	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12.raw	12	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 203	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12.raw	12	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 203	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12.raw	12	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 203	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12.raw	12	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 203	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12.raw	12	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 204	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12r.raw	12	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 204	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12r.raw	12	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 204	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12r.raw	12	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 204	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12r.raw	12	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 204	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12r.raw	12	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 204	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT12r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT12r.raw	12	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 205	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13.raw	13	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 205	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13.raw	13	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 205	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13.raw	13	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 205	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13.raw	13	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 205	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13.raw	13	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 205	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13.raw	13	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 206	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13r.raw	13	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 206	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13r.raw	13	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 206	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13r.raw	13	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 206	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13r.raw	13	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 206	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13r.raw	13	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 206	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT13r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT13r.raw	13	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 207	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14.raw	14	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 207	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14.raw	14	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 207	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14.raw	14	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 207	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14.raw	14	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 207	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14.raw	14	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 207	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14.raw	14	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 208	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14r.raw	14	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 208	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14r.raw	14	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 208	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14r.raw	14	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 208	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14r.raw	14	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 208	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14r.raw	14	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 208	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT14r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT14r.raw	14	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 209	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15.raw	15	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 209	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15.raw	15	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 209	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15.raw	15	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 209	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15.raw	15	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 209	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15.raw	15	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 209	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15.raw	15	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 210	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15r.raw	15	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 210	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15r.raw	15	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 210	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15r.raw	15	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 210	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15r.raw	15	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 210	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15r.raw	15	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 210	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT15r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT15r.raw	15	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 211	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16.raw	16	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 211	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16.raw	16	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 211	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16.raw	16	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 211	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16.raw	16	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 211	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16.raw	16	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 211	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16.raw	16	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 212	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16r.raw	16	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 212	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16r.raw	16	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 212	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16r.raw	16	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 212	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16r.raw	16	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 212	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16r.raw	16	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 212	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT16r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT16r.raw	16	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 213	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17.raw	17	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 213	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17.raw	17	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 213	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17.raw	17	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 213	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17.raw	17	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 213	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17.raw	17	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 213	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17.raw	17	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 214	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17r.raw	17	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 214	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17r.raw	17	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 214	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17r.raw	17	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 214	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17r.raw	17	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 214	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17r.raw	17	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 214	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT17r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT17r.raw	17	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 215	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2.raw	2	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 215	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2.raw	2	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 215	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2.raw	2	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 215	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2.raw	2	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 215	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2.raw	2	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 215	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2.raw	2	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 216	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2r.raw	2	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 216	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2r.raw	2	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 216	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2r.raw	2	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 216	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2r.raw	2	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 216	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2r.raw	2	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 216	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT2r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT2r.raw	2	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 217	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3.raw	3	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 217	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3.raw	3	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 217	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3.raw	3	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 217	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3.raw	3	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 217	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3.raw	3	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 217	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3.raw	3	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 218	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3r.raw	3	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 218	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3r.raw	3	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 218	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3r.raw	3	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 218	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3r.raw	3	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 218	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3r.raw	3	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 218	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT3r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT3r.raw	3	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 219	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4.raw	4	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 219	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4.raw	4	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 219	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4.raw	4	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 219	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4.raw	4	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 219	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4.raw	4	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 219	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4.raw	4	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 220	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4r.raw	4	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 220	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4r.raw	4	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 220	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4r.raw	4	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 220	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4r.raw	4	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 220	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4r.raw	4	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 220	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT4r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT4r.raw	4	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 221	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5.raw	5	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 221	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5.raw	5	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 221	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5.raw	5	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 221	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5.raw	5	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 221	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5.raw	5	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 221	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5.raw	5	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 222	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5r.raw	5	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 222	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5r.raw	5	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 222	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5r.raw	5	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 222	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5r.raw	5	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 222	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5r.raw	5	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 222	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT5r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT5r.raw	5	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 223	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6.raw	6	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 223	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6.raw	6	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 223	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6.raw	6	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 223	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6.raw	6	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 223	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6.raw	6	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 223	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6.raw	6	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 224	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6r.raw	6	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 224	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6r.raw	6	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 224	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6r.raw	6	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 224	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6r.raw	6	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 224	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6r.raw	6	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 224	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT6r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT6r.raw	6	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 225	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7.raw	7	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 225	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7.raw	7	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 225	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7.raw	7	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 225	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7.raw	7	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 225	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7.raw	7	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 225	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7.raw	7	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 226	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7r.raw	7	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 226	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7r.raw	7	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 226	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7r.raw	7	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 226	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7r.raw	7	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 226	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7r.raw	7	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 226	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT7r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT7r.raw	7	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 227	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8.raw	8	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 227	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8.raw	8	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 227	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8.raw	8	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 227	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8.raw	8	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 227	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8.raw	8	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 227	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8.raw	8	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 228	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8r.raw	8	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 228	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8r.raw	8	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 228	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8r.raw	8	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 228	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8r.raw	8	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 228	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8r.raw	8	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 228	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT8r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT8r.raw	8	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 229	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9.raw	9	1	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 229	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9.raw	9	1	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 229	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9.raw	9	1	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 229	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9.raw	9	1	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 229	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9.raw	9	1	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 229	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9.raw	9	1	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 31	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 230	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9r.raw	9	2	TMT126	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 32	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 230	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9r.raw	9	2	TMT127	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	IC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 33	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	IC	run 230	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9r.raw	9	2	TMT128	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 34	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC	run 230	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9r.raw	9	2	TMT129	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 35	plasmodium falciparum	human erythrocytes	schizont	not applicable	1	no enrichment	not applicable	EC-BA	run 230	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9r.raw	9	2	TMT130	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
Sample 36	plasmodium falciparum	not applicable	not applicable	not applicable	1	not applicable	not applicable	not applicable	run 230	proteomic profiling by mass spectrometry	3D7	PXD015093	NT=Data-dependent acquisition;AC=PRIDE:0000627	3plex_exp2_FT9r.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/03/PXD015093/3plex_exp2_FT9r.raw	9	2	TMT131	AC=MS:1003096;NT=LTQ Orbitrap Velos Pro	AC=PRIDE:0000590;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Phospho;AC=UNIMOD:21;TA=S,T,Y;MT=Variable	5 ppm	0.5 Da	not applicable	EC-BA	v1.1.0	NT=ms-proteomics;version=v1.1.0
